Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (366 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 03 Nov 2021 – 20 Aug 2026, limited by HDFC NIFTY Next 50 index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | HDFC NIFTY Next 50 index Fund | Nifty 50 |
|---|---|---|
| 03 Nov 2021 | ₹100.00 | ₹100.00 |
| 29 Mar 2022 | ₹95.37 | ₹97.17 |
| 22 Aug 2022 | ₹98.95 | ₹98.10 |
| 15 Jan 2023 | ₹98.19 | ₹100.71 |
| 10 Jun 2023 | ₹99.32 | ₹104.12 |
| 03 Nov 2023 | ₹104.30 | ₹107.86 |
| 28 Mar 2024 | ₹140.93 | ₹125.23 |
| 20 Aug 2024 | ₹171.61 | ₹138.53 |
| 13 Jan 2025 | ₹142.20 | ₹129.48 |
| 08 Jun 2025 | ₹157.20 | ₹140.24 |
| 01 Nov 2025 | ₹161.84 | ₹144.27 |
| 27 Mar 2026 | ₹143.87 | ₹127.99 |
| 20 Aug 2026 | ₹172.29 | ₹135.91 |
| Metric | HDFC · Regular NAV ₹17.21 Very High risk ★★★★☆ | Category median Index Funds · 366 funds |
|---|---|---|
| +9.02% | +5.43% | |
| +19.17% | +8.41% | |
| — | +8.95% | |
| — | +11.28% | |
| +12.02% | +7.40% | |
| +14.37% | — | |
| +17.78% | +11.37% | |
| — | +13.00% | |
| — | +11.07% | |
| Risk | ||
| 18.43% | 13.88% | |
| 0.69 | 0.25 | |
| 0.92 | 0.35 | |
| -26.78% | -16.66% | |
| Nifty 50 | — | |
| +9.80% | +0.30% | |
| 1.30 | 1.00 | |
| 142.8% | 101.3% | |
| 97.4% | 98.8% | |
| 0.72% | 0.96% | |
| ₹2,399Cr | ₹182.17Cr | |
| None | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 27% | 35% | |
| Arun Agarwal | — | |
| 03 Nov 2021 | — | |
| 50 | — | |
| 32.2% | — | |
| 0.2% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.